AFLAC Incorporated (NYSE:AFL) has been assigned an average recommendation of “Hold” from the thirteen research firms that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $51.80.
AFL has been the topic of several recent analyst reports. Raymond James downgraded shares of AFLAC from a “strong-buy” rating to an “outperform” rating and set a $62.00 price objective on the stock. in a research note on Monday. UBS Group reduced their price objective on shares of AFLAC from $50.00 to $49.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 30th. Evercore ISI downgraded shares of AFLAC from an “in-line” rating to an “underperform” rating and set a $56.57 price objective on the stock. in a research note on Tuesday, July 16th. Barclays upped their price objective on shares of AFLAC from $45.00 to $53.00 and gave the company an “equal weight” rating in a research note on Wednesday, May 22nd. Finally, ValuEngine downgraded shares of AFLAC from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd.
In related news, insider Teresa L. White sold 57,124 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $50.39, for a total transaction of $2,878,478.36. Following the completion of the transaction, the insider now owns 76,378 shares of the company’s stock, valued at $3,848,687.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Toshihiko Fukuzawa sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $51.00, for a total transaction of $76,500.00. Following the transaction, the director now directly owns 12,816 shares of the company’s stock, valued at approximately $653,616. The disclosure for this sale can be found here. Insiders have sold 158,604 shares of company stock valued at $8,184,068 in the last ninety days. 1.30% of the stock is currently owned by company insiders.
Shares of NYSE AFL traded down $0.33 on Thursday, hitting $52.31. The company’s stock had a trading volume of 4,363,737 shares, compared to its average volume of 3,195,666. AFLAC has a 12-month low of $41.45 and a 12-month high of $57.18. The stock has a market cap of $38.99 billion, a P/E ratio of 12.57, a price-to-earnings-growth ratio of 2.94 and a beta of 0.72. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.04 and a quick ratio of 0.05. The company has a 50 day simple moving average of $55.22.
AFLAC (NYSE:AFL) last announced its quarterly earnings data on Thursday, July 25th. The financial services provider reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.06. The business had revenue of $5.51 billion for the quarter, compared to the consensus estimate of $5.46 billion. AFLAC had a net margin of 14.24% and a return on equity of 12.94%. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.07 earnings per share. On average, sell-side analysts forecast that AFLAC will post 4.34 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 3rd. Investors of record on Wednesday, August 21st will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 2.06%. The ex-dividend date is Tuesday, August 20th. AFLAC’s dividend payout ratio (DPR) is 25.96%.
Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
Featured Article: What is the Federal Reserve?
Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.